Thursday, December 17, 2009

Need Help Paying for Pulmozyme?

Genentech® is committed to helping patients get access to the Pulmozyme® (dornase alfa) Inhalation Solution prescribed by their physicians. If you're having concerns about paying for Pulmozyme, we're here to help. Pulmozyme Access Solutions helps resolve specific access and reimbursement issues for individual patients every day. Our specialists are passionate about helping you access Pulmozyme and exploring every appropriate solution to coverage or reimbursement issues

Am I eligible?
You may be referred to a co-pay assistance program if you have:
* Public insurance (e.g., Medicare, Medicaid)
* Private insurance

Help for the Uninsured
The Genentech® Access to Care Foundation (GATCF)* was established to help qualified patients who are uninsured or who have been rendered uninsured because they have been denied coverage by their insurance company.
If you have no insurance or your health insurance plan has denied your Pulmozyme (dornase alfa) treatment, you can apply to GATCF to receive your medicine free of charge.

To learn more about Genentech's support offerings, call (800) 690-3023 from 6 AM to 5PM PT, Monday to Friday to speak live with one of our specialists, or visit Pulmozyme Access Solutions Website.